Workflow
生物股份(600201) - 2023 Q3 - 季度财报
600201JINYU(600201)2023-10-30 16:00

Financial Performance - The net profit attributable to shareholders of the listed company increased by 46.38% in the reporting period, primarily due to enhanced sales from new product promotions and improved marketing capabilities [18]. - Net profit attributable to shareholders for the first three quarters of 2023 was RMB 288,309,346.90, reflecting a growth of 37.24% year-on-year [36]. - The net profit attributable to shareholders after deducting non-recurring gains and losses for the first three quarters of 2023 was RMB 265,495,845.69, up 25.71% from the previous year [36]. - The basic and diluted earnings per share for the reporting period were both RMB 0.26, an increase from RMB 0.19 in the same period last year [14]. - Basic earnings per share for the third quarter of 2023 was RMB 55.56, driven by the increase in net profit attributable to shareholders [37]. - The net profit for Q3 2023 was approximately ¥285.76 million, an increase from ¥204.57 million in the same period last year [57]. - The total profit for Q3 2023 was approximately ¥330.76 million, compared to ¥235.20 million in the previous year [57]. Cash Flow and Liquidity - The total operating cash inflow for the first three quarters of 2023 was approximately RMB 1,256.79 million, compared to RMB 1,073.03 million in the same period of 2022, reflecting a significant increase [15]. - The net cash flow generated from operating activities for the first three quarters of 2023 was RMB 295.45 million, up from RMB 210.77 million in the previous year [15]. - The cash received from the sale of goods and services was RMB 1,150.68 million, compared to RMB 982.54 million in the same period of 2022, indicating strong sales growth [15]. - The net cash flow from operating activities for the year-to-date period increased by 40.18%, primarily due to higher cash receipts from sales [37]. - The net cash flow from operating activities for Q3 2023 was approximately ¥295.45 million, representing a 40.18% increase compared to the previous period [45]. - The company’s cash and cash equivalents increased to approximately ¥1.80 billion, up from ¥1.41 billion at the end of the previous year [52]. Assets and Equity - The company's total equity attributable to shareholders reached RMB 5,324.21 million as of September 30, 2023, compared to RMB 5,072.20 million at the end of the previous year [12]. - Total assets as of the reporting date amounted to RMB 6,799,784,587.68, compared to RMB 6,389,335,025.55 at the end of the previous year [22]. - The total current assets increased to RMB 3,191,462,824.67 from RMB 2,680,672,552.30 in the previous year [22]. - The total non-current assets decreased to RMB 3,608,321,763.01 from RMB 3,708,662,473.25 in the previous year [22]. - The equity attributable to shareholders of the listed company was approximately ¥5.32 billion, reflecting a 4.97% increase compared to the previous year [45]. - The company's total liabilities as of September 30, 2023, were approximately ¥1.18 billion, compared to ¥1.04 billion at the end of the previous year [54]. Comprehensive Income - The company's total comprehensive income for the reporting period was RMB 288.47 million, compared to RMB 210.28 million in the previous year [14]. - Non-operating income for the reporting period amounted to CNY 11,740,363.62, a decrease from CNY 22,813,501.21 in the previous period, reflecting a significant decline of approximately 48.6% [65]. - Government subsidies recognized in the current period totaled CNY 14,143,354.99, down from CNY 27,719,137.53 in the previous period, indicating a reduction of about 48.9% [64]. Shareholder Information - The total number of common shareholders at the end of the reporting period was 56,321, with the largest shareholder holding 10.92% of the shares [67].